Your browser doesn't support javascript.
loading
Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomas.
Yin, Jinlong; Jung, Ji-Eun; Choi, Sun Il; Kim, Sung Soo; Oh, Young Taek; Kim, Tae-Hoon; Choi, Eunji; Lee, Sun Joo; Kim, Hana; Kim, Eun Ok; Lee, Yu Sun; Chang, Hee Jin; Park, Joo Yong; Kim, Yeejeong; Yun, Tak; Heo, Kyun; Kim, Youn-Jae; Kim, Hyunggee; Kim, Yun-Hee; Park, Jong Bae; Choi, Sung Weon.
Afiliação
  • Yin J; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea; Rare Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Jung JE; Rare Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea; Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
  • Choi SI; Molecular Imaging Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea; Department of Life Science, Ewha Womans University, Seoul, Republic of Korea.
  • Kim SS; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.
  • Oh YT; Rare Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.
  • Kim TH; Rare Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Choi E; Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.
  • Lee SJ; Molecular Imaging Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Kim H; Molecular Imaging Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Kim EO; Molecular Imaging Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Lee YS; Molecular Imaging Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Chang HJ; Department of Pathology and Precision Medicine Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Park JY; Oral Oncology Clinic, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Kim Y; Department of Pathology, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
  • Yun T; Rare Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Heo K; Immunotherapeutics Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Kim YJ; Translational Research Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Kim H; Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
  • Kim YH; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea; Molecular Imaging Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Park JB; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea; Rare Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Choi SW; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea; Rare Cancer Branch, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea; Oral Oncology Clinic, Research Institute and Hospital, Nat
Cancer Lett ; 414: 181-189, 2018 02 01.
Article em En | MEDLINE | ID: mdl-29154973
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Ensaios Antitumorais Modelo de Xenoenxerto Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Medicamentos Antineoplásicos / Ensaios Antitumorais Modelo de Xenoenxerto Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article